rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Bruker Corporation

BRKR · Nasdaq

Health CareLife-science toolsLeading

BRKR stood above a rising 150-day average in 36 of the last 52 weekly readings, including each of the last 24 weeks. It is 5.6% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
24 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$6.7M
Officials’ trades on record
7
Institutions holding
382 (+64)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 36 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$4.0M$0$4.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

7 disclosed lines: House 3, Senate 3, executive 1; 4 people.

WhoDidAmountTraded
Stephen I. Miran Executive branch: Office of Government EthicsCouncil of Economic Adviserssold$15k–$50k9 Jun 2025filed 6 Sep 2025
Thomas R. Carper Senate: U.S. Senate eFDSenatorsoldspouse$1k–$15k17 Apr 2023filed 1 May 2023
Bob Gibbs House: U.S. House ClerkOH07sold$1k–$15k27 Nov 2020filed 24 Dec 2020
Thomas R. Carper Senate: U.S. Senate eFDSenatorboughtspouse$1k–$15k20 Nov 2020filed 17 May 2021
Thomas R. Carper Senate: U.S. Senate eFDSenatorboughtspouse$1k–$15k20 Nov 2020filed 2 Dec 2020
Bob Gibbs House: U.S. House ClerkOH07bought$1k–$15k14 Nov 2019filed 26 Nov 2019
Donna E. Shalala House: U.S. House ClerkFL27sold$1k–$15k24 Jun 2019filed 27 Apr 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 4
WhoDidSharesTraded
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $52.8715 Sep 2026filed 16 Sep 2026
Wolfgang PuschPresident BMID Groupsold3,473at $56.9017 Aug 2026filed 18 Aug 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $57.6014 Aug 2026filed 18 Aug 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $60.2515 Jul 2026filed 16 Jul 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $54.7615 Jun 2026filed 16 Jun 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $43.9015 May 2026filed 18 May 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $39.9015 Apr 2026filed 16 Apr 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $35.4413 Mar 2026filed 16 Mar 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $36.9413 Feb 2026filed 18 Feb 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold2,000at $49.2015 Jan 2026filed 16 Jan 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold7,000at $55.0012 Jan 2026filed 13 Jan 2026
Mark MunchEXEC VP&PRES BRUKER NANO INC.sold4,506at $50.005 Jan 2026filed 6 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders382+64 on the quarter
New · exited111 · 47
Reported value$8.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 202620,237,425$1.2B+4,135,622+25.7%
Orbis Allan Gray Ltdunchanged · filed 14 Aug 202617,940,076$1.1B00.0%
BlackRock, Inc.added · filed 7 Aug 202611,407,332$686.5M+226,526+2.0%
Pallas Capital Advisors LLCadded · filed 7 Aug 20269,483,978$570.7M+2,1570.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20264,888,290$294.2M+32,375+0.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20264,859,252$292.4M+42,176+0.9%
Sculptor Capital LPadded · filed 14 Aug 20264,625,000$278.3M+1,355,000+41.4%
STATE STREET CORPadded · filed 7 Aug 20264,017,673$241.9M+108,980+2.8%
FRANKLIN RESOURCES INCadded · filed 13 Aug 20263,229,337$194.3M+310,160+10.6%
Sachem Head Capital Management LPnew · filed 14 Aug 20262,915,000$175.4M+2,915,000
31 Mar 2023 – 30 Jun 2026
257317377Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Mark Munch Company insiderEXEC VP&PRES BRUKER NANO INC. · last 15 Sep 20260 · 16
Wolfgang Pusch Company insiderPresident BMID Group · last 17 Aug 20260 · 1
Burkhard Prause Company insiderPRES. & CEO, BRUKER BEST · last 15 Aug 20260 · 4
Frank H. Laukien Company insiderPRESIDENT & CEO · last 15 Aug 202677 · 16
Gerald N. Herman Company insiderEXECUTIVE VICE PRESIDENT, CFO · last 15 Aug 20260 · 1
Juergen Srega Company insiderPRESIDENT CALID · last 15 Aug 20260 · 1
Thomas Bures Company insiderChief Accounting Officer · last 15 Aug 20261 · 0
Thierry Bernard Company insiderDirector · last 15 May 20260 · 0
Adelene Q. Perkins Company insiderDirector · last 15 Feb 20260 · 0
Bob Rosenthal Company insiderDirector · last 15 Feb 20260 · 1
Bonnie H. Anderson Company insiderDirector · last 15 Feb 20260 · 0
Cynthia M. Friend Company insiderDirector · last 15 Feb 20260 · 8

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202545.9%
Operating profit marginFY 2025 · to 31 Dec 20252.0%
Free cash flow marginFY 2025 · to 31 Dec 20251.3%
Return on capital employedFY 2025 · to 31 Dec 20251.4%
Cash conversionFY 2024 · to 31 Dec 2024222%
Debt to equityFY 2025 · to 31 Dec 20250.76×
Interest coverFY 2024 · to 31 Dec 20245.28×
Research spendFY 2025 · to 31 Dec 202511.5%
Share count trendFY 2024 · to 24 Feb 20250.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$298.8M
Free cash flowFY 2025 · to 31 Dec 2025$43.3M

Analyst forecasts

No analyst forecasts yet.